Abstract
The viruses causing the SARS outbreak of 2002-2003 and current COVID-19 pandemic are related betacoronaviruses. What insights were learned from SARS that can inform SARS-CoV-2 vaccine development? Focusing on important lessons from SARS vaccine development and two SARS vaccines evaluated in humans may guide SARS-CoV-2 vaccine design, testing, and implementation.
Copyright © 2020 Elsevier Inc. All rights reserved.
MeSH terms
-
Animals
-
Antibodies, Neutralizing
-
Betacoronavirus / immunology*
-
COVID-19
-
COVID-19 Vaccines
-
Clinical Trials as Topic / standards
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / prevention & control*
-
Humans
-
Pandemics / prevention & control*
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / prevention & control*
-
SARS-CoV-2
-
Severe Acute Respiratory Syndrome / prevention & control
-
Severe acute respiratory syndrome-related coronavirus / immunology
-
Spike Glycoprotein, Coronavirus / immunology
-
Viral Vaccines / immunology*
-
Viral Vaccines / standards
Substances
-
Antibodies, Neutralizing
-
COVID-19 Vaccines
-
Spike Glycoprotein, Coronavirus
-
Viral Vaccines
-
spike protein, SARS-CoV-2